Xponance, Inc. Biomarin Pharmaceutical Inc Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Xponance, Inc. holds 29,428 shares of BMRN stock, worth $1.96 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

29,428

Previous 29,307 0.41%

Holding current value

$1.96 Million

Previous $2.41 Million 14.26%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$69.02 - $93.84 $8,351 - $11,354	121 Added 0.41%	29,428 $2.07 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $871,500 - $1.08 Million	11,709 Added 66.54%	29,307 $2.41 Million
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $723,447 - $854,568	8,632 Added 96.27%	17,598 $1.54 Million
Q4 2023 Jan 31, 2024	SELL	$76.22 - $98.51 $15,472 - $19,997	-203 Reduced 2.21%	8,966 $864,000
Q3 2023 Oct 23, 2023	BUY	$85.07 - $94.48 $19,225 - $21,352	226 Added 2.53%	9,169 $811,000
Q2 2023 Jul 13, 2023	BUY	$86.68 - $100.3 $209,938 - $242,926	2,422 Added 37.14%	8,943 $775,000
Q1 2023 Apr 17, 2023	BUY	$87.74 - $117.27 $1,579 - $2,110	18 Added 0.28%	6,521 $634,000
Q4 2022 Jan 23, 2023	BUY	$80.93 - $108.63 $236,234 - $317,090	2,919 Added 81.45%	6,503 $0
Q3 2022 Oct 24, 2022	BUY	$82.16 - $96.94 $9,201 - $10,857	112 Added 3.23%	3,584 $304,000
Q2 2022 Aug 02, 2022	BUY	$71.48 - $86.85 $248,178 - $301,543	3,472 New	3,472 $288,000
Q3 2021 Nov 05, 2021	SELL	$74.77 - $85.47 $205,318 - $234,700	-2,746 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $1.07 Million - $1.2 Million	-14,189 Reduced 83.79%	2,746 $229,000
Q1 2021 May 10, 2021	SELL	$74.73 - $90.69 $10,910 - $13,240	-146 Reduced 0.85%	16,935 $1.28 Million
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $5,155 - $6,404	71 Added 0.42%	17,081 $1.5 Million
Q3 2020 Oct 26, 2020	SELL	$71.87 - $131.03 $1,509 - $2,751	-21 Reduced 0.12%	17,010 $1.29 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $1.35 Million - $2.12 Million	17,031 New	17,031 $2.1 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account